Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Hughes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Experimental Physiology|September 1, 1993
Neural modulation of bovine mesenteric lymph node contractionG A Hughes, J M Allen
British Journal of Biomedical Science|March 1, 1995
Detection of reverse transcriptase in culture medium for mammary tumour cell lines: a comparison of an established radio-labelling technique and a contemporary non-isotopic techniqueG A Hughes, Y A Barnett, J M Allen
Nature|October 27, 1988
Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNAM M Pater, G A Hughes, D E Hyslop, et al.
Journal of Medicinal Chemistry|December 6, 1996
Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesicsR Wrigglesworth, C S Walpole, S Bevan, et al.
Journal of Medicinal Chemistry|June 24, 1994
The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxinC S Walpole, S Bevan, G Bovermann, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Design of non-peptide CCK2 and NK1 peptidomimetics using 1-(2-nitrophenyl)thiosemicarbazide as a novel common scaffoldE K Dziadulewicz, C S Walpole, C R Snell, et al.
Journal of Medicinal Chemistry|August 14, 1998
2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain modelsC Walpole, S Y Ko, M Brown, et al.
British Journal of Pharmacology|February 29, 2000
Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesiaG M Burgess, M N Perkins, H P Rang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Experimental Physiology|September 1, 1993
Neural modulation of bovine mesenteric lymph node contractionG A Hughes, J M Allen
British Journal of Biomedical Science|March 1, 1995
Detection of reverse transcriptase in culture medium for mammary tumour cell lines: a comparison of an established radio-labelling technique and a contemporary non-isotopic techniqueG A Hughes, Y A Barnett, J M Allen
Nature|October 27, 1988
Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNAM M Pater, G A Hughes, D E Hyslop, et al.
Journal of Medicinal Chemistry|December 6, 1996
Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesicsR Wrigglesworth, C S Walpole, S Bevan, et al.
Journal of Medicinal Chemistry|June 24, 1994
The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxinC S Walpole, S Bevan, G Bovermann, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Design of non-peptide CCK2 and NK1 peptidomimetics using 1-(2-nitrophenyl)thiosemicarbazide as a novel common scaffoldE K Dziadulewicz, C S Walpole, C R Snell, et al.
Journal of Medicinal Chemistry|August 14, 1998
2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain modelsC Walpole, S Y Ko, M Brown, et al.
British Journal of Pharmacology|February 29, 2000
Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesiaG M Burgess, M N Perkins, H P Rang, et al.
Pageof 1